QualityStocks Stock Newsletters Archives - Page 226 of 1818

FridayMay 20, 2011 8:48 am

PolyMedix, Inc.’s (PYMX) Lead Antibiotic Compound Demonstrates Positive Results against Cancer Treatment Complications

PolyMedix Inc., a biotech company focused on developing new therapeutic drugs to treat patients with acute infectious diseases and cardiovascular disorders, today announced that its lead antibiotic compound PMX-30063 has shown activity against oral mucositis, which is debilitating inflammation and ulceration in the mouth associated with complications of cancer treatment. The results were demonstrated when PMX-30063 was orally administered in an animal study. Stephen T. Sonis, DMD, DMSc, is chief medical officer at Biomodes, the facility where the studies were performed. Sonis said the results were “exciting” and emphasized the importance of PMX-30063’s performance in the study. “Radiation and chemotherapy…

FridayMay 20, 2011 8:46 am

Environmental Tectonics Corp. (ETCC) Announces Formation of NASTAR Foundation

Environmental Tectonics Corp. recently announced the formation of the NASTAR Foundation. This non-profit organization fosters opportunities for people of all ages to experience the excitement of aerospace exploration. The NASTAR Foundation's core focus areas are to inspire, facilitate, and grow public awareness and participation in aviation and space activities; enhance workforce development through life-long learning opportunities, and support innovative programs that improve science, technology, engineering and mathematics (STEM) education. In addition, core focus areas are to facilitate theoretical and applied research to meet the needs of the aerospace industry, and advance health & safety via the creation of medical and…

FridayMay 20, 2011 8:44 am

Affymetrix Inc. (AFFX) Launches Customizable Genotype Technology

Affymetrix Inc., a provider of technology used by top pharmaceutical, diagnostic and biotechnology companies, as well as by academic, government and nonprofit research institutes, has rolled-out its Axiom myDesign Targeted Genotyping Arrays to help researchers study disease mutations and characterize gene-gene interactions. The technology provides researchers the ability to design custom arrays to genotype 1,500 to 2.6 million markers per sample; from there, researchers can transition from genome-wide scans to zero-in on specific analyses using various approaches on the same platform. “Axiom myDesign TG Arrays will help researchers to quickly evaluate interesting variants from their GWAS, sequencing and candidate gene…

ThursdayMay 19, 2011 3:21 pm

Pure Bioscience, Inc. (PURE) Gets Good News on SDC

PURE Bioscience, developers of bioscience products for combating stubborn bacteria such as Staph (MRSA), announced today that its patented antimicrobial product SDC (silver dihydrogen citrate) has been shown to be effective based upon tests conducted by the University of Medicine & Dentistry of New Jersey. The tests demonstrated SDC’s effectiveness against bacterial films, common in any nutrient-sufficient ecosystems, such as oral cavities. Dr. Narayanan Ramasubbu, Associate Professor with the Department of Oral Biology at the university, described the study and its results. “We have used SDC against single species biofilms of Aggregatibacter actinomycetemcomitans, a causative agent in localized aggressive periodontitis,…

ThursdayMay 19, 2011 12:56 pm

China Carbon Graphite Group, Inc. (CHGI) Announces Q1 2011 Results

China Carbon Graphite Group, Inc., China’s biggest wholesaler of fine-grain and high-purity graphite, has just announced its Q1 2011 results. For the quarter ended March 31, 2011, the company disclosed that revenues jumped 137%, from $4.85 million in Q1 2010 to $11.46 million in Q1 2011, while its net income rose 139%, from $0.86 million in Q1 2010 losses to its current $0.33 million positive net. The company’s EBITDA metric for Q1 2011 soared to $2.52 million, a 155% gain over its Q1 2010 level of $0.99 million. China Carbon CEO Donghai Yu commented particularly on the EBITDA rise, saying,…

ThursdayMay 19, 2011 12:31 pm

Agenus Inc. (AGEN) Announces Presentation of New Phase 2 Trial Data on Glioma Vaccine

Agenus Inc. just announced that it will be presenting new data from a Phase 2 trial of the Prophage G-200 vaccine (HSPPC-96; vitespen) in recurrent glioma. The company intends making a poster presentation during the 2011 ASCO Annual Meeting, slated for June 3-7 in Chicago, IL. Abstracts are now available at ASCO’s website www.chicago2011.asco.org. The abstract (#2565), by Parsa, et al, is titled "Autologous heat shock protein vaccine (HSPPC-96) for patients with recurrent glioblastoma (GBM): Results of a Phase 2 multicenter clinical trial with immunological assessments.” According to the company, its Prophage vaccines are “patient-specific therapeutic cancer vaccine candidates.” Prophage…

ThursdayMay 19, 2011 12:28 pm

White Mountain Titanium Corp. (WMTM) Reports on Mining Project in Chile

White Mountain Titanium Corp. issued an operational update on the company’s titanium mining property in South America. The company also provided fundamental information on supply and demand trends in the worldwide titanium market. White Mountain Titanium owns 38 mining concessions consisting of approximately 8,225 hectares at the Cerro Blanco project in Chile. The company is currently exploring at the Las Carolinas prospect on its properties. White Mountain Titanium completed an infill drilling program at the prospect in April 2011 and is currently updating the company’s resource model and designing a mining program. The drill program obtained approximately 7,000 meters of…

ThursdayMay 19, 2011 11:01 am

May Selling Adage Challenged by Bullish Markets, Fed Easing and Social Media

Bouman and Jacobsen called it the Halloween Indicator, attempting to drill down into the psychological and logistical complexities behind the ‘Sell in May and Go Away’ adage in their paper on the subject. They described the May-October period as seasonally down in some 36 out of 37 developed/emerging markets studied, with European markets showing the strongest adherence. Indeed, by DJIA measure stocks have on the average climbed 7.4% in the Nov. 1- Apr. 30 period since the 1950’s, mapping only 0.4% for the following May-Oct. period. Moreover, some of the worst six-month intervals have occurred during this period and the…

ThursdayMay 19, 2011 10:48 am

Cavico Corp. (CAVO) to Participate in Coal Mine Project in Vietnam

Cavico Corp. is an infrastructure, construction and natural resources conglomerate based in Vietnam. The company's main focus is on infrastructure projects such as the construction of hydropower facilities, dams, bridges, tunnels, roads and buildings. However, it is also investing into other areas like cement, mineral and metals exploration, and urban development. The company today announced that Vietnam's Prime Minister NguyenTan Dung has approved its proposal for a project to construct a vertical coal mine shaft in Vietnam. Cavico will be the first domestic construction contractor to build a vertical coal mine shaft in Vietnam and is not required to go…

ThursdayMay 19, 2011 10:19 am

Cleantech Transit Inc. (CLNO) Provides Investment Community with Corporate Update

Cleantech Transit Inc., a company focused on capitalizing on technology advances and manufacturing opportunities in the growing clean energy public transportation sector, was pleased to provide a corporate update on company operations today. Cleantech continues to focus its efforts on developing an asset base in the environmentally-friendly biomass arena with the previously announced 500 kilowatt project. The company anticipates providing further details on the status of the biomass facility over the coming weeks. Cleantech has also been evaluating additional projects that may match the company's corporate objectives. Additionally, efforts are underway to continue strengthening the management team as the company…

Site Search

Company Search

Category: QualityStocks Stock Newsletters